1141-P: Detailed Phenotype of Randomized Participants by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
ARODA V, KRAUSE-STEINRAUF H, BUSE J, GULANSKI B, FLOREZ H, AHMANN A, LOVELAND A, KUHN A, LONIER J, MATHER K, WEXLER D. 1141-P: Detailed Phenotype of Randomized Participants by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes 2019, 68 DOI: 10.2337/db19-1141-p.Peer-Reviewed Original ResearchNovo Nordisk A/SMannKind CorporationBaseline characteristicsKidney diseaseSpouse/partnerInclusion criteriaClinical phenotypeAge groupsGlycemia Reduction ApproachesComparative effectiveness studiesDistinct clinical phenotypesNational InstituteEli LillyAdvisory PanelEisai Inc.More CVDProminent hyperglycemiaSecond medicationAdvancing Translational SciencesDiabetic dyslipidemiaMore medicationsPrevalent comorbiditiesRandomized participantsAge-related differencesRandomized treatment